Correlation Between PDS Biotechnology and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and ATyr Pharma, you can compare the effects of market volatilities on PDS Biotechnology and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and ATyr Pharma.
Diversification Opportunities for PDS Biotechnology and ATyr Pharma
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between PDS and ATyr is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and ATyr Pharma go up and down completely randomly.
Pair Corralation between PDS Biotechnology and ATyr Pharma
Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 0.43 times more return on investment than ATyr Pharma. However, PDS Biotechnology Corp is 2.32 times less risky than ATyr Pharma. It trades about -0.06 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.07 per unit of risk. If you would invest 535.00 in PDS Biotechnology Corp on August 28, 2024 and sell it today you would lose (318.00) from holding PDS Biotechnology Corp or give up 59.44% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 44.02% |
| Values | Daily Returns |
PDS Biotechnology Corp vs. ATyr Pharma
Performance |
| Timeline |
| PDS Biotechnology Corp |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
PDS Biotechnology and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PDS Biotechnology and ATyr Pharma
The main advantage of trading using opposite PDS Biotechnology and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| PDS Biotechnology vs. Eliem Therapeutics | PDS Biotechnology vs. HCW Biologics | PDS Biotechnology vs. Scpharmaceuticals | PDS Biotechnology vs. Milestone Pharmaceuticals |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |